NDRA ENDRA Life Sciences Inc

Price (delayed)

$6.5

Market cap

$9.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.32

Enterprise value

$5.19M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 89
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 8

ENDRA Life Sciences is the pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS ® ), a ground-breaking technology being developed to assess tissue fat content and monitor tissue ablation during minimally invasive ...

Highlights
The company's quick ratio has surged by 124% YoY
ENDRA Life Sciences's net income has increased by 32% YoY and by 19% from the previous quarter
The company's EPS has shrunk by 152% YoY but it rose by 22% QoQ
The debt has increased by 11% YoY and by 3.7% from the previous quarter

Key stats

What are the main financial stats of NDRA

NDRA stock price

How has the ENDRA Life Sciences stock price performed over time
Intraday
4.33%
1 week
22.64%
1 month
44.77%
1 year
35.42%
YTD
43.49%
QTD
21.95%

Financial performance

How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.65M
Net income
-$5.92M
Gross margin
N/A
Net margin
N/A
ENDRA Life Sciences's net income has increased by 32% YoY and by 19% from the previous quarter
The operating income rose by 22% year-on-year but it has declined by 2.8% since the previous quarter

Price vs fundamentals

How does NDRA's price correlate with its fundamentals

Growth

What is ENDRA Life Sciences's growth rate over time

Valuation

What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
1.31
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 152% YoY but it rose by 22% QoQ
NDRA's P/B is 84% less than its last 4 quarters average of 7.6 and 58% less than its 5-year quarterly average of 3.0

Efficiency

How efficient is ENDRA Life Sciences business performance
The return on equity has surged by 56% since the previous quarter and by 21% year-on-year
The company's return on invested capital rose by 44% YoY and by 29% QoQ
The ROA has increased by 43% since the previous quarter and by 26% year-on-year

Dividends

What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NDRA.

Financial health

How did ENDRA Life Sciences financials performed over time
NDRA's total assets has soared by 183% year-on-year and by 131% since the previous quarter
The company's quick ratio has surged by 124% YoY
The debt is 84% less than the equity
The debt to equity has shrunk by 73% YoY and by 70% QoQ
The debt has increased by 11% YoY and by 3.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.